Oral cannabidivarin (CBDV) solution for treatment of HIV-associated neuropathic pain – a randomized, double-blind, placebo-controlled phase II study.
Phase of Trial: Phase II
Latest Information Update: 13 Apr 2017
At a glance
- Drugs Cannabidivarin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- 01 Sep 2015 New trial record